As healthcare companies seek to adapt and thrive in a fast-changing environment, M&A is playing a crucial role
As healthcare companies seek to adapt and thrive in a fast-changing environment, M&A is playing a crucial role. The numbers bear this out: There were 579 deals for U.S. healthcare targets in 2017, the second-highest total on record, according to Mergermarket data. The appetite for deals is fueling a highly favorable market for seller. For instance, the median EBITDA multiple for U.S. healthcare targets increased nearly 3x from 2015 to 2017, reaching the level of 13.8x.
Both up and down market, a common theme in healthcare M&A has emerged: Buyers are looking for acquisitions that can evolve and respond to the rapidly changing landscape. Big insurers are joining forces with distributors to create new, vertically integrated structures. Private equity firms are consolidating fragmented sub-sectors and investing in technology that can reduce costs and change how care is delivered.
Indeed, leveraging innovation to save on costs is a key motivation for healthcare M&A deals. "Everything is about cost take-out, given the amount of competitive pressure in the industry," said Brad Haller, a director in West Monroe's M&A practice who focuses on healthcare deals. "All of the different stakeholders are trying to outdo each other on price."
To better understand the drivers and challenges for healthcare acquirers - and to analyze the role of technology in healthcare M&A - West Monroe conducted a survey of 100 market practitioners in partnership with Mergermarket. The survey indicates that the healthcare sector's robust financial performance will drive dealmaking amid heightened competition for targets. Acquirers are leveraging domain expertise and forming novel alliances to win deals and create value post-close. Technological change is at the forefront, as buyers use M&A to gain access to technology and disrupt the completion, Yet our study shows that due diligence in the areas of IT and cybersecurity - which have become cornerstones of the modern healthcare industry - often fall short.
The race for assets is likely to heat up further as strategic buyers and private equity firms look to put capital to work. The task for acquirers is to place the right bets in this dynamic market.
How pharma companies can enhance patient support programs with generative AI
This is Digital, Episode 16: From healthcare company to product company: Highmark's journey
The innovation landscape is rapidly changing—and increasingly distributed